Tacsure 0.5
Tacrolimus IP
0.5 mg · capsules
Calcineurin inhibitor for prophylaxis of organ rejection. Narrow therapeutic index.
At a glance.
| Brand name | Tacsure 0.5 |
|---|---|
| Composition | Tacrolimus IP |
| Strength | 0.5 mg |
| Dosage form | Capsules |
| Care segment | Transplant care |
| Pack size | TBC — client to supply |
| Storage | TBC — client to supply |
| Schedule | Prescription only Verify schedule |
| Shelf life | TBC — client to supply |
| Manufactured by | TBC — client to supply |
What it is used for.
Calcineurin inhibitor indicated for prophylaxis of organ rejection in renal transplant recipients. Narrow therapeutic index — dose titrated to whole-blood trough concentration.
Indication summary written for orientation only. Full prescribing information, dosing and contraindications are supplied to registered healthcare professionals on request.
Where it sits in the pathway
Related products.
Tacsure 1.0
Tacrolimus IP
1 mg · capsules
The 1 mg presentation, used alone or with the 0.5 mg strength to titrate to target trough.
Trough level View details Transplant careMofisure
Mycophenolic acid delayed-release USP
360 mg · delayed-release tablets
Antiproliferative immunosuppressant, used as part of a maintenance regimen after renal transplant.
Rejection risk ↓ View details Transplant careValsure
Valganciclovir hydrochloride USP (eq. to valganciclovir)
450 mg · film-coated tablets
Antiviral used for cytomegalovirus prophylaxis and treatment in transplant recipients.
CMV prophylaxis View detailsNeed this product for a patient this week?
Tell us the unit and the quantity. We will confirm availability and the nearest stockist.